June 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
Market insights predict, the autoimmune disease diagnostics industry is expected to grow from USD 5.75 billion in 2024 to USD 10.5 billion by 2034, driven by a CAGR of 6.22%. Globally, rising incidences and breakthroughs in technologies in autoimmune disease diagnostics are driving the market expansion. North America led the respective market, due ...
April 21, 2026
The global LC-MS/MS-based diagnostics market is growing because of the rising demand for diagnostic services. North America is leading the market due to the region’s focus on developing highly advanced healthcare infrastructure....
April 21, 2026
The market is growing due to rising infectious disease cases and the need for rapid, accurate diagnostics. Advancements in technologies like PCR and NGS are further driving demand across the healthcare and food safety sectors....
April 21, 2026
Based on market forecasts, the global specialty control plasma market, projected at USD 10.42 billion in 2024, is expected to reach USD 19.42 billion by 2034, growing at a CAGR of 6.44% over the forecast period. The global specialty control plasma market is growing due to growing advancements in diagnostics services. North America is dominating the...
April 21, 2026
Projections indicate that, the global strand displacement amplification (SDA) market will increase from USD 1.66 billion in 2025 to USD 2.45 billion by 2035, experiencing a CAGR of 3.96% over the next 10 years. The strand displacement amplification (SDA) market is expected to grow rapidly due to the growing demand for diagnostics services, es...
April 21, 2026
Market insights predict the global genomic urine testing industry will increase from USD 148.23 million in 2024 to USD 319.14 million by 2034, achieving a CAGR of 7.94%. The genomic urine testing market is growing due to its enhanced ability to predict various severe conditions, such as bladder cancer. This testing can predict and avoid diseases in...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the market. The availability of a robust healthcare infrastructure and favorable reimbursement policies ...
April 21, 2026
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is growing due to their role in many diseases, like cancer, autoimmune diseases, and psychiatric disorders....
April 21, 2026
Market insights predict the global cellular health screening industry will increase from USD 3.37 billion in 2024 to USD 8.14 billion by 2034, achieving a CAGR of 9.24%. The rising prevalence of chronic disorders and technological advancements drive the global market. Whereas, the presence of a robust healthcare infrastructure and increasing invest...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
